Cas:1216893-18-3 Bupropion morpholinol D6 manufacturer & supplier

Chemical Name:Bupropion morpholinol D6

CAS.NO:1216893-18-3

Synonyms:2-(3-chlorophenyl)-3-methyl-5,5-bis(triddeuteromethyl)morpholin-2-ol;Hydroxy Bupropion D6

Molecular Formula:C₁₃H₁₂D₆ClNO₂

Molecular Weight:261.78

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:41.49000

Exact Mass:

LogP:2.60080

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-(3-chlorophenyl)-3-methyl-5,5-bis(triddeuteromethyl)morpholin-2-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Hydroxy Bupropion D6 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(3-chlorophenyl)-3-methyl-5,5-bis(triddeuteromethyl)morpholin-2-ol Use and application,2-(3-chlorophenyl)-3-methyl-5,5-bis(triddeuteromethyl)morpholin-2-ol technical grade,usp/ep/jp grade.

Related News: It has contracted with the Chinese manufacturer Xiamen Biotime Biotechnology to produce the tests for international distribution. According to Innova, Biotime previously submitted performance data to the agency without seeking an EUA, while the company later presented equivalent data for the same test under the Innova brand. Bupropion morpholinol D6 manufacturer As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials. Bupropion morpholinol D6 supplier Alira’s work spans the gamut from transaction advisory to regulatory services to advanced analytics, management consulting, product development and clinical investigator training, to name a few. With the CROS NT deal, Alira secures not only a biometrics presence but also a portfolio of electronic data capture systems. Bupropion morpholinol D6 vendor As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials. Bupropion morpholinol D6 factory It has contracted with the Chinese manufacturer Xiamen Biotime Biotechnology to produce the tests for international distribution. According to Innova, Biotime previously submitted performance data to the agency without seeking an EUA, while the company later presented equivalent data for the same test under the Innova brand.